European Medicines Agency has determined that the AstraZeneca vaccine is related to the formation of rare blood clots.
UK health officials have recommended that people under the age of 30 get a different vaccine if possible.
Reporter Jeon Hyeong-woo reports.
European Medicines Agency has revealed that the AstraZeneca Corona 19 vaccine may be related to the formation of rare blood clots.
He decided that rare blood clots that result in platelet loss should be included in the very rare side effects of the AstraZeneca vaccine.
[Emer Cook/Director of the European Medicines Agency: Rare blood clots reported after vaccination with the AstraZeneca vaccine should be included as possible side effects.]
However, this vaccine, which is effective against Corona 19, has a greater benefit than the side effects of the AstraZeneca vaccine. I saw that I had to keep using it.
As controversy over the occurrence of blood clots grew, the UK also recommended that people under the age of 30 avoid vaccination against the AstraZeneca vaccine, a pharmaceutical company in their country.
[Jun Lane/British Medicines Regulatory Authority: In the report, the risk of this type of rare blood clot is around 4 in 1 million.]
British health officials said, "Not because of serious safety concerns, but to be careful." Added.
Belgium has also decided to give the AstraZeneca vaccine only to the elderly over the age of 56.
The Belgian Ministry of Health has required a different vaccine for ages 18 to 55, while the vaccine is being reevaluated for at least 4 weeks.
The World Health Organization's Vaccine Safety Advisory Committee says the causal relationship between the AstraZeneca vaccine and the rare cases of blood clot formation appears to be valid, but has not been confirmed, and requires specialized research.